Omacor: all 89 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Immunonutrition for Diabetic Foot UlcersTerminatedNCT05281562Phase 2/3Results posted
• QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03387098Phase 1/2Results posted
• QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03329248Phase 1/2Results posted
• A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEICompletedNCT02370537Phase 2Results posted
• An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of PancreatitisCompletedNCT02189252Phase 1Results posted
• Fish Oils and Adipose Inflammation ReductionCompletedNCT02010359Phase 4Results posted
• Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese WomenCompletedNCT01894581Not applicableResults posted
• COGNUTRIN in Breast Cancer SurvivorsCompletedNCT01823991Early Phase 1Results posted
• Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced InflammationCompletedNCT01813110Not applicableResults posted
• Effect of Omega-3 Fatty Acid on Vitamin D ActivationCompletedNCT01596842Phase 4Results posted
• Breast Cancer Risk Biomarkers in Postmenopausal WomenCompletedNCT01252290Phase 2Results posted
• Breast Cancer Risk Biomarkers in Premenopausal WomenCompletedNCT01252277Phase 2Results posted
• Epanova® for Lowering Very High TriglyceridesCompletedNCT01242527Phase 2/3Results posted
• n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial FibrillationCompletedNCT01198275Phase 3Results posted
• The Effects of Lovaza® in Acute Myocardial InfarctionTerminatedNCT01155336Phase 1/2Results posted
• Oral Omega-3 Fatty Acids in the Treatment of Dry Eye SyndromeCompletedNCT01107964Not applicableResults posted
• Fenofibrate and Omega-3 Fatty Acid Modulation of EndotoxemiaCompletedNCT01048502Not applicableResults posted
• The Impact of Omega Three Fatty Acids on Vascular Function in HIVCompletedNCT01041521Phase 4Results posted
• Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With HypertriglyceridemiaCompletedNCT01034540Not applicableResults posted
• Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected SubjectsCompletedNCT01010399Phase 4Results posted
• Feasibility Study of Omega-3 Fatty Acids in Dialysis PatientsTerminatedNCT01002118Not applicableResults posted
• Pilot Placebo Controlled Study With Lovaza in Cardiovascular DiseaseCompletedNCT01001767Phase 2Results posted
• Effects of Lovaza on Lipoprotein Composition and Function in Mild HypertriglyceridemiaCompletedNCT00959842Phase 1/2Results posted
• The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart FailureTerminatedNCT00944229Phase 3Results posted
• Lovaza® and Microvascular Function in Type 2 DiabetesCompletedNCT00931879Phase 4Results posted
• Fish Oil Study for High Triglyceride Levels in ChildrenCompletedNCT00915902Phase 2/3Results posted
• Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic SubjectsCompletedNCT00903409Phase 3Results posted
• Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)TerminatedNCT00845845Phase 2Results posted
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaCompletedNCT00833976Phase 4Results posted
• The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory MarkersCompletedNCT00805870Phase 2Results posted
• Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) TrialCompletedNCT00795717Phase 4Results posted
• Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty AcidsCompletedNCT00760513Phase 4Results posted
• Effects of Prescription Omega-3 on LDL-C in Primary HypercholesterolemiaCompletedNCT00746811Phase 4Results posted
• Women With Chest Pain and Normal Coronary Arteries StudyTerminatedNCT00743197Not applicableResults posted
• An Open-label Extension to Assess the Continued Efficacy of Omacor Plus SimvastatinCompletedNCT00678743Phase 4Results posted
• Trial of Lovaza in Adolescents With Mild to Moderately Elevated TriglyceridesTerminatedNCT00672633Phase 2Results posted
• Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DMCompletedNCT00577590Not applicableResults posted
• Lovaza's Effect on the Activation of PlateletsCompletedNCT00515541Phase 2Results posted
• Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated TriglyceridesCompletedNCT00504309Not applicableResults posted
• Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With HypertriglyceridemiaCompletedNCT00435045Phase 3Results posted
• Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial FibrillationCompletedNCT00402363Phase 3Results posted
• Niacin, N-3 Fatty Acids and Insulin ResistanceCompletedNCT00286234Phase 4Results posted
• The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)CompletedNCT00069784Phase 3Results posted
• The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac SurgeryTerminatedNCT06434948Phase 2
• Pro-Resolving Mediators in Acute Inflammation in HumansCompletedNCT04308889Early Phase 1
• Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)Active, not recruitingNCT03831698Phase 2
• Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current SmokersActive, not recruitingNCT03598309Phase 2
• Phase I Drug-drug Interaction of Omega-3 and AtorvastatinStatus unknownNCT03438955Phase 1
• QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyWithdrawnNCT03197584Phase 1/2
• QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03197571Phase 1/2
• QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyWithdrawnNCT03175666Phase 1/2
• QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLWithdrawnNCT03169790Phase 1/2
• QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCWithdrawnNCT03169777Phase 1/2
• QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03169764Phase 1/2
• QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
• QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03167177Phase 1/2
• QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyWithdrawnNCT03167164Phase 1/2
• The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal TransplantationCompletedNCT03018041Phase 3
• Breast, Omega 3 Free Fatty Acid, Ph 0CompletedNCT02996240Not applicable
• Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary TissueWithdrawnNCT01784042Early Phase 1
• An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic PatientsCompletedNCT01725646Phase 3
• Slowing HEART diSease With Lifestyle and Omega-3 Fatty AcidsCompletedNCT01624727Not applicable
• Lovaza's Effect on Clopidogrel in a Neuro PopulationStatus unknownNCT01526824Early Phase 1
• The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal SubjectsCompletedNCT01486433Phase 1
• Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat MealsCompletedNCT01431690Phase 1
• OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial DiseaseCompletedNCT01367145Phase 3
• The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver DiseaseCompletedNCT01277237Phase 3
• Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood DisordersStatus unknownNCT01216982Phase 2
• Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver DiseaseWithdrawnNCT01191177Phase 1/2
• Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in HypertriglyceridemiaWithdrawnNCT01180764Phase 4
• Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 SupplementationStatus unknownNCT01157780Not applicable
• Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney DiseaseCompletedNCT01092390Phase 3
• Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac SurgeryStatus unknownNCT01046604Phase 4
• Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT00941642Phase 4
• Triglyceride Lowering StudyStatus unknownNCT00934219Phase 4
• n-3 Polyunsaturated Fatty Acids in ObesityCompletedNCT00760760Phase 2
• The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic PatientsStatus unknownNCT00758927Phase 4
• Study of Fish Oil to Reduce ALT Levels in AdolescentsTerminatedNCT00694746Phase 1
• Effects of Omacor and Aspirin on Platelet FunctionCompletedNCT00688961Early Phase 1
• Effect of Omacor on Triglycerides in HIV Infected SubjectsTerminatedNCT00598910Phase 4
• Lovaza Therapy of Peripheral Arterial DiseaseWithdrawnNCT00569686Not applicable
• Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A NephropathyCompletedNCT00549692Phase 3
• Omacor for Perimenopausal DepressionWithdrawnNCT00517972Phase 2
• Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular ArrhythmiaWithdrawnNCT00507390Phase 4
• The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery DiseaseCompletedNCT00454493Not applicable
• Efficacy of Omega-3 Fatty Acids on Borderline Personality DisorderStatus unknownNCT00437099Phase 4
• Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes MellitusCompletedNCT00328536Phase 4
• Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic SubjectsCompletedNCT00246701Phase 3
• Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart FailureCompletedNCT00149409Phase 2/3

← Omacor overview